- Filed
- May 5, 2022 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · May 2, 2022 | 27.61M sh |
| Shares Diluted | Q1 2022 · Mar 31, 2022 | 27.34M sh |
| Shares Diluted | Q1 2022 · Mar 31, 2021 | 26.74M sh |
| Operating Cash Flow | Q1 2022 · Mar 31, 2022 | −$18.33M |
| Operating Cash Flow | Q1 2022 · Mar 31, 2021 | −$18.25M |
| Long Term Debt | Q1 2022 · Mar 31, 2022 | $339.97M |
| Long Term Debt | Q1 2022 · Dec 31, 2021 | $297.07M |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $29.66M |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $11.78M |
| Stockholders Equity | Q1 2022 · Mar 31, 2022 | −$54.82M |
| Stockholders Equity | Q1 2022 · Dec 31, 2021 | −$33.69M |
| Current Liabilities | Q1 2022 · Mar 31, 2022 | $193.27M |
| Current Liabilities | Q1 2022 · Dec 31, 2021 | $161.85M |
| Total Liabilities | Q1 2022 · Mar 31, 2022 | $550.15M |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $479.17M |
| Current Assets | Q1 2022 · Mar 31, 2022 | $324.72M |
| Current Assets | Q1 2022 · Dec 31, 2021 | $273.16M |
| Total Assets | Q1 2022 · Mar 31, 2022 | $488.5M |
| Total Assets | Q1 2022 · Dec 31, 2021 | $438.92M |
| Eps Diluted | Q1 2022 · Mar 31, 2022 | −$0.98 |
| Eps Diluted | Q1 2022 · Mar 31, 2021 | −$0.55 |
| Eps Basic | Q1 2022 · Mar 31, 2022 | −$0.98 |
| Eps Basic | Q1 2022 · Mar 31, 2021 | −$0.55 |
| Sga Expense | Q1 2022 · Mar 31, 2022 | $33.77M |
| Sga Expense | Q1 2022 · Mar 31, 2021 | $33.78M |
| Net Income | Q1 2022 · Mar 31, 2022 | −$26.68M |
| Net Income | Q1 2022 · Mar 31, 2021 | −$14.81M |
| Operating Income | Q1 2022 · Mar 31, 2022 | −$13.56M |
| Operating Income | Q1 2022 · Mar 31, 2021 | $6.78M |
| Gross Profit | Q1 2022 · Mar 31, 2022 | $20.21M |
| Gross Profit | Q1 2022 · Mar 31, 2021 | $40.56M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2022 | $160.65M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2021 | $158.63M |
| Revenue | Q1 2022 · Mar 31, 2022 | $180.86M |
| Revenue | Q1 2022 · Mar 31, 2021 | $199.19M |